.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Teva
Express Scripts
Fuji
Medtronic
Novartis
Dow
Accenture
Cerilliant

Generated: December 18, 2017

DrugPatentWatch Database Preview

Epinephrine bitartrate; lidocaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for epinephrine bitartrate; lidocaine hydrochloride and what is the scope of epinephrine bitartrate; lidocaine hydrochloride patent protection?

Epinephrine bitartrate; lidocaine hydrochloride
is the generic ingredient in two branded drugs marketed by Deproco and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for epinephrine bitartrate; lidocaine hydrochloride. Fifteen suppliers are listed for this compound.

Summary for epinephrine bitartrate; lidocaine hydrochloride

Pharmacology for epinephrine bitartrate; lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
DeprocoLIGNOSPAN STANDARDepinephrine bitartrate; lidocaine hydrochlorideINJECTABLE;INJECTION088390-001Jan 22, 1985RXNoYes► Subscribe► Subscribe► Subscribe
DeprocoLIGNOSPAN FORTEepinephrine bitartrate; lidocaine hydrochlorideINJECTABLE;INJECTION088389-001Jan 22, 1985RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
McKinsey
Express Scripts
AstraZeneca
US Department of Justice
Argus Health
Queensland Health
Teva
Daiichi Sankyo
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot